MARP protein family: A possible role in molecular mechanisms of tumorigenesis

Journal of Medical Biochemistry

Volumn 29, Issue 3, 2010, Pages 157-164

  Kojić, Snežana ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

MARPs; p53; tumorigenesis

Indexed keywords

ANKYRIN; ANKYRIN REPEAT DOMAIN 2 PROTEIN; CARDIAC ANKYRIN REPEAT PROTEIN; CISPLATIN; DIABETES ASSOCIATED ANKYRIN REPEAT PROTEIN; MUSCLE ANKYRIN REPEAT PROTEIN; PLATINUM DERIVATIVE; PROTEIN P53; UNCLASSIFIED DRUG;

CARCINOGENESIS; CONGESTIVE CARDIOMYOPATHY; DIFFERENTIAL DIAGNOSIS; DUCHENNE MUSCULAR DYSTROPHY; GENE MUTATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MYOPATHY; NUCLEAR LOCALIZATION SIGNAL; ONCOCYTOMA; OVARY CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; RHABDOMYOSARCOMA; SPINAL MUSCULAR ATROPHY; STRUCTURE ANALYSIS;

EID: 77955238689     PISSN: 14528258     EISSN: 14528266     Source Type: Journal    
DOI: 10.2478/v10011-010-0024-9     Document Type: Review

References (61)

1. Miller MK, Bang ML, Witt CC, Labeit D, Trombitas C, Watanabe K, et al. The muscle ankyrin repeat proteins: CARP Ankrd2/Arpp and DARP as a family of titin filament-based stress response molecules. J Mol Biol 2003; 333: 951-964
2. Bang ML, Mudry RE, McElhinny AS, Trombitas K, Geach AJ, Yamasaki R, et al. Myopalladin, a novel 145- kilodalton sarcomeric protein with multiple roles in Z- disc and I-band protein assemblies. J Cell Biol 2001; 153:413-427
3. Chu W, Burns DK, Swerlick RA, Presky DH. Identification and characterization of a novel cytokine- inducible nuclear protein from human endothelial cells. J Biol Chem 1995; 270: 10236-10245
4. Zou Y, Evans S, Chen J, Kuo H, Harvey RP Chien KR. CARF, a cardiac ankyrin repeat protein, is downstream in the Nkx2-5 homeobox gene pathway. Development 1997;124: 793-804.
5. Jeyasseelan R, Poizat C, Baker RK, Abdishoo S, Iste- rabadi LB, Lyons GE, et al. A novel cardiac-restricted target for doxorubicin. CARF, a nuclear modulator of gene expression in cardiac progenitor cells and cardio- myocytes. J Biol Chem 1997; 272: 22800-22808
6. Aihara Y, Kurabayashi M, Saito Y, Ohyama Y, Tanaka T, Takeda S, et al. Cardiac ankyrin repeat protein is a novel marker of cardiac hypertrophy: role of M-CAT element within the promoter. Hypertension 2000; 36: 48-53.
7. Baumeister A, Arber S, Caroni P Accumulation of muscle ankyrin repeat protein transcript reveals local activation of primary myotube endcompartments during muscle morphogenesis. J Cell Biol 1997; 139: 1231-1242
8. Tsukamoto Y, Senda T, Nakano T, Nakada C, Hida T, Ishiguro N, et al. Arpp, a new homolog of carp, is preferentially expressed in type 1 skeletal muscle fibers and is markedly induced by denervation. Lab Invest 2002; 82: 645-655
9. Chen YW, Nader GA, Baar KR, Fedele MJ, Hoffman EP Esser KA. Response of rat muscle to acute resistance exercise defined by transcriptional and translational profiling. J Physiol 2002; 545: 27-41.
10. Carson JA, Nettleton D, Reecy JM. Differential gene expression in the rat soleus muscle during early work overload-induced hypertrophy. FASEB J 2002; 16: 207-209
11. Kanai H, Tanaka T, Aihara Y, Takeda S, Kawabata M, Miyazono K, et al. Transforming growth factor- beta/Smads signaling induces transcription of the cell type-restricted ankyrin repeat protein CARP gene through CAGA motif in vascular smooth muscle cells. Circ Res 2001; 88: 30-36
12. Laure L, Suel L, Roudaut C, Bourg N, Ouali A, Bartoli M, et al. Cardiac ankyrin repeat protein is a marker of skeletal muscle pathological remodeling. FEBS J 2009; 276: 669-684
13. Torrado M, Nespereira B, Lopez E, Centeno A, Castro- Beiras A, Mikhailov AT. ANKRD1 specifically binds CASQ2 in heart extracts and both proteins are co- enriched in piglet cardiac Purkinje cells. J Mol Cell Cardiol 2005; 38: 353-365
14. Witt SH, Labeit D, Granzier H, Labeit S, Witt CC. Dimerization of the cardiac ankyrin protein CARP: implications for MARP titin-based signaling. J Muscle Res Cell Motil 2005; 26: 401-408
15. Witt CC, Witt SH, Lerche S, Labeit D, Back W, Labeit S. Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2. EMBO J 2008; 27: 350-360
16. Kemp TJ, Sadusky TJ, Saltisi F, Carey N, Moss J, Yang SY et al. Identification of Ankrd2, a novel skeletal muscle gene coding for a stretch-responsive ankyrin- repeat protein. Genomics 2000; 66: 229-241
17. Pallavicini A, Kojic S, Bean C, Vainzof M, Salamon M, Ievolella C, et al. Characterization of human skeletal muscle Ankrd2. Biochem Biophys Res Commun 2001; 285:378-386
18. Barash IA, Mathew L, Ryan AF, Chen J, Lieber RL. Rapid muscle-specific gene expression changes after a single bout of eccentric contractions in the mouse. Am J Physiol Cell Physiol 2004; 286: 355-364
19. Hentzen ER, Lahey M, Peters D, Mathew L, Barash IA, Friden J, et al. Stress-dependent and independent expression of the myogenic regulatory factors and the MARP genes after eccentric contractions in rats. J Physiol 2006; 570: 157-167
20. Kojic S, Medeot E, Guccione E, Krmac H, Zara I, Martinelli V, et al. The Ankrd2 protein, a link between the sarcomere and the nucleus in skeletal muscle. J Mol Biol 2004; 339: 313-325
21. Tsukamoto Y, Hijiya N, Yano S, Yokoyama S, Nakada C, Uchida T, et al. Arpp/Ankrd2, a member of the muscle ankyrin repeat proteins (MARPs), translocates from the I-band to the nucleus after muscle injury. Histochem Cell Biol 2008; 129: 55-64.
22. Zolk O, Frohme M, Maurer A, Kluxen FW, Hentsch B, Zubakov D, et al. Cardiac ankyrin repeat protein, a negative regulator of cardiac gene expression, is augmented in human heart failure. Biochem Biophys Res Commun 2002; 293: 1377-1382
23. Cinquetti R, Badi I, Campione M, Bortoletto E, Chiesa G, Parolini C, et al. Transcriptional deregulation and a missense mutation define ANKRD1 as a candidate gene for total anomalous pulmonary venous return. Hum Mutat 2008; 29: 468-474
24. Moulik M, Vatta M, Witt SH, Arola AM, Murphy RT, McKenna WJ, et al. ANKRD1, the gene encoding cardiac ankyrin repeat protein, is a novel dilated cardiomyopathy gene. J Am Coll Cardiol 2009; 54: 325-333
25. Duboscq-Bidot L, Charron P Ruppert V Fauchier L, Richter A, Tavazzi L, et al. Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathy. Eur Heart J 2009; 302: 128-136
26. Arimura T, Bos JM, Sato A, Kubo T, Okamoto H, Nishi H, et al. Cardiac ankyrin repeat protein gene (ANKRD1) mutations in hypertrophic cardiomyopathy. J Am Coll Cardiol 2009; 54: 334-342
27. Nakada C, Tsukamoto Y, Oka A, Nonaka I, Takeda S, Sato K, et al. Cardiac-restricted ankyrin-repeated protein is differentially induced in Duchenne and congenital muscular dystrophy. Lab Invest 2003; 83: 711-719
28. Nakada C, Oka A, Nonaka I, Sato K, Mori S, Ito H, et al. Cardiac ankyrin repeat protein is preferentially induced in atrophic myofibers of congenital myopathy and spinal muscular atrophy. Pathol Int 2003; 53: 653-658
29. Nakada C, Tsukamoto Y, Oka A, Nonaka I, Sato K, Mori S, et al. Altered expression of ARPP protein in skeletal muscles of patients with muscular dystrophy, congenital myopathy and spinal muscular atrophy. Pathobiology 2004; 71:43-51.
30. Altmannsberger M, Weber K, Droste R, Osborn M. Desmin is a specific marker for rhabdomyosarcomas of human and rat origin. Am J Pathol 1985; 118: 85-95.
31. Brooks JJ. Immunohistochemistry of soft tissue tumors. Myoglobin as a tumor marker for rhabdomyosarcoma. Cancer 1982; 50: 1757-1763
32. Schmidt RA, Cone R, Haas JE, Gown AM. Diagnosis of rhabdomyosarcomas with HHF35, a monoclonal antibody directed against muscle actins. Am J Pathol 1988; 131: 19-28.
33. Wijnaendts LC, van der Linden JC, van Unnik AJ, Delemarre JFF Voute PA, Meijer CJ. The expression pattern of contractile and intermediate filament proteins in developing skeletal muscle and rhabdo- myosarcoma of childhood: diagnostic and prognostic utility. J Pathol 1994; 174: 283-292
34. Tallini G, Parham DM, Dias P Cordon-Cardo C, Houghton PJ, Rosai J. Myogenic regulatory protein expression in adult soft tissue sarcomas. A sensitive and specific marker of skeletal muscle differentiation. Am J Pathol 1994; 144: 693-701.
35. Wang NP Marx J, McNutt MA, Rutledge JC, Gown AM. Expression of myogenic regulatory proteins (myogenin and MyoD1) in small blue round cell tumors of childhood. Am J Pathol 1995; 147: 1799-1810
36. Cessna MH, Zhou H, Perkins SL, Tripp SR, Layfield L, Daines C, et al. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics. Am J Surg Pathol 2001; 25: 1150-1157
37. Ishiguro N, Baba T, Ishida T, Takeuchi K, Osaki M, Araki N, et al. Carp, a cardiac ankyrin-repeated protein, and its new homologue, Arpp, are differentially expressed in heart, skeletal muscle, and rhabdomyosarcomas. Am J Pathol 2002; 160: 1767-1778
38. Ishiguro N, Motoi T, Osaki M, Araki N, Minamizaki T, Moriyama M, et al. Immunohistochemical analysis of a muscle ankyrin-repeat protein, Arpp, in paraffin- embedded tumors: evaluation of Arpp as a tumor marker for rhabdomyosarcoma. Hum Pathol 2005; 36: 620-625
39. Ishiguro N, Motoi T, Araki N, Ito H, Moriyama M, Yoshida H. Expression of cardiac ankyrin repeat protein, CARP in malignant tumors: diagnostic use of CARP protein immunostaining in rhabdomyosarcoma. Hum Pathol 2008; 39: 1673-1679
40. Lieber MM. Renal oncocytoma: prognosis and treatment. Eur Urol 1990; 18: 17-21.
41. Zerban H, Nogueira E, Riedasch G, Bannasch P Renal oncocytoma: origin from the collecting duct. Virchows Arch B Cell Pathol Incl Mol Pathol 1987; 52: 375-387
42. Morra MN, Das S. Renal oncocytoma: a review of histogenesis, histopathology, diagnosis and treatment. J Urol 1993; 150: 295-302.
43. Shomori K, Nagashima Y, Kuroda N, Honjo A, Tsukamoto Y, Tokuyasu N, et al. ARPP protein is selectively expressed in renal oncocytoma, but rarely in renal cell carcinomas. Modern Pathology 2007; 20: 199-207.
44. Scurr LL, Guminski AD, Chiew YE, Balleine RL, Sharma R, Lei Y, et al. Ankyrin repeat domain 1, ANKRD1, a novel determinant of cisplatin sensitivity expressed in ovarian cancer. Clin Cancer Res 2008; 14: 6924-6932
45. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
46. Finlay CA, Hinds PW, Levine AJ. The p53 proto- oncogene can act as a suppressor of transformation. Cell 1989; 57: 1083-1093
47. Koshland DE Jr. Molecule of the year. Science 1993; 262: 1953.
48. Vazquez A, Bond EE, Levine AJ, Bond GL. The genetics of the p53 pathway, apoptosis and cancer therapy. Nat Rev Drug Discov 2008; 7: 979-987
49. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408: 307-310
50. Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997; 387: 296-299
51. Kubbutat MH, Jones SN, Vousden KH. Regulation of p53 stability by Mdm2. Nature 1997; 387: 299-303.
52. Giaccia AJ, Kastan MB. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev 1998; 12: 2973-2983
53. Ko LJ, Prives C. p53: puzzle and paradigm. Genes Dev 1996; 10: 1054-1072
54. Leri A, Claudio PP, Li Q, Wang X, Reiss K, Wang S, et al. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2- to-Bax protein ratio in the cell. J Clin Invest 1998; 101: 1326-1342
55. Taira N, Nihira K, Yamaguchi T, Miki Y, Yoshida K. DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage. Mol Cell 2007; 25: 725-738
56. Rinaldo C, Prodosmo A, Mancini F, Iacovelli S, Sacchi A, Moretti F, et al. MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis. Mol Cell 2007; 25: 739-750
57. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T, et al. Database of p53 gene somatic Mutations in human tumors and cell lines. Nucleic Acids Res 1994; 22: 3551-3555 (Pubitemid 24299821)
58. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997; 88: 323-331
59. Freedman DA, Levine AJ. Regulation of the p53 protein by the MDM2 oncoprotein. Cancer Res 1999; 59: 1-7.
60. Freedman DA, Wu L, Levine AJ. Functions of the MDM2 oncoprotein. Cell Mol Life Sci 1999; 55: 96-107.
61. Labbe E, Lock L, Letamendia A, Gorska AE, Gryfe R, Gallinger S, et al. Transcriptional cooperation between the transforming growth factor-b and Wnt pathways in mammary and intestinal tumorigenesis. Cancer Res 2007; 67: 75-84.